Select your timezone:

Clinical Islets

Thursday October 21, 2021 - 15:45 to 17:05

Room: Virtual Room 1

207.8 Association of circulating miRNAs with clinical parameters in patients undergoing Total Pancreatectomy with Islet Auto-Transplantation (TPIAT)

Srividya Vasu, United States

Postdoctoral Fellow
Islet Cell Lab
BAYLOR SCOTT AND WHITE HEALTH RESEARCH Institute

Abstract

Association of circulating miRNAs with clinical parameters in patients undergoing Total Pancreatectomy with Islet Auto-Transplantation (TPIAT)

Srividya Vasu1, Giovanna Saracino2, Carly M. Darden3, Yang Liu2, Michael C. Lawrence1, Bashoo Naziruddin2.

1Islet Cell Lab, Baylor Scott and White Health Research Institute, Dallas, TX, United States; 2Baylor Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX, United States; 3Baylor University, Waco, TX, United States

Introduction: For patients with refractory Chronic Pancreatitis (CP), TPIAT procedure improves chronic pain and prevents brittle diabetes. Our preliminary studies revealed that circulating miR-375, miR-29b-3p, miR-216a-5p, miR-200c-3p and miR-148a-3p were elevated during islet infusion in TPIAT patients. Aims of this study are to investigate circulating microRNA (miRNA) profiles in patients before, during and after TPIAT with a view to understanding their associations with clinical parameters.

Methods: Small RNA sequencing was performed on miRNAs isolated from plasma samples collected from patients before TPIAT (n = 18) and from healthy donors (n = 6). Selected miRNA candidates were validated in a larger cohort of 40 CP patients using miRCURY LNA SYBR green qPCR assays using plasma collected at four time-points: pre-TPIAT, 6 h after islet infusion, 3 months and 1 year after transplantation. Correlation analyses were performed using R software (Version 4.1.0).

Results: Small RNA sequencing revealed that 38 miRNAs were significantly elevated and 5 miRNAs were significantly reduced in circulation compared to healthy controls (p<0.05, p<0.01). Of these, miR-148a-3p, miR-99b-5p, miR-221-3p, miR-122-5p, let-7e-5p, miR-375, miR-200c-3p, miR-29b-3p, miR-7-5p, miR-216a-5p, miR-125b-5p and miR-320d were selected for further investigations. Time-course analysis revealed that miR-375, miR-216a-5p, miR-122-5p were significantly elevated at 6 h after islet infusion (p<0.001) and normalized to pre-TPIAT levels by 3 months after TPIAT. At 3 months and 1 year after TPIAT, circulating levels of miR-29b-3p, miR-125b-5p, miR-7-5p, let-7e-5p and miR-99b-5p were significantly elevated compared to pre-TPIAT levels (p<0.05, p<0.01, p<0.001). Association analyses of circulating levels of miRNAs measured at pre-TPIAT and 6 h after islet infusion time-points are provided in Table 1 and 2 respectively. Interestingly, miR-29b-3p, miR-221-3p, miR-99b-5p, miR-125b-5p and let-7e-5p measured at 3 months were directly associated with insulin requirement (Units/kg body weight) at 1 year after TPIAT (p<0.05). Circulating miR-221-3p and miR-122-5p measured at 1 year after TPIAT were inversely associated with basal secretory unit of islet transplant objects (SUITO) index at 1 year after TPIAT (p<0.05).

Conclusion: Pre-TPIAT levels of hsa-miR-29b-3p, hsa-miR-221-3p, hsa-miR-99b-5p, hsa-let-7e-5p and hsa-miR-320d were associated directly or inversely with post-transplant functional measures (Table 1). Circulating levels of 11 out of the 12 miRNAs tested at 6 h after islet infusion were associated directly or inversely with post-transplant functional measures (Table 2). Further investigations using larger sample size are necessary to establish the predictive potential of selected miRNA candidates.


We acknowledge technical assistance by Mrs Ana Rahman.